(Q36407375)

14 August 2017

1 reference

title

Pramipexole for the treatment of restless legs syndrome (English)

1 reference

14 August 2017

main subject

restless legs syndrome

0 references

author name string

Clete A Kushida

series ordinal

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Expert Opinion on Pharmacotherapy

14 August 2017

published in

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

441-451

1 reference

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Genetics in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Objective structured clinical examinations (OSCE) for sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Effect of pramipexole in treatment of resistant restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Restless legs syndrome augmentation and pramipexole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Pergolide-induced pleuropulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Daytime sleepiness and other sleep disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

FAST TRACK: daytime sleepiness in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

An algorithm for the management of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

Clinical Characteristics of Pramipexole-Induced Peripheral Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.4.441

21 January 2018

Identifiers

DOI

10.1517/14656566.7.4.441

1 reference

14 August 2017

1 reference